Category:RANK ligand inhibitors

From - A Hematology Oncology Wiki
Jump to navigation Jump to search

A class of drugs that inhibit the receptor activator of nuclear factor kappa-B ligand (RANKL). Currently Denosumab (Xgeva) is the only FDA-approved drug in this class.

Pages in category "RANK ligand inhibitors"

This category contains only the following page.